α/β- and β-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age
CONCLUSIONS: Carvedilol administration during pregnancy was associated with neonatal hypoglycemia; however, it did not occur in a time- or dose-dependent manner. Routine monitoring of blood glucose levels in newborns exposed to α/β- and β-blockers is essential.PMID:36823100 | DOI:10.1253/circj.CJ-22-0647
Source: Circulation Journal - Category: Cardiology Authors: Kana Kubota Kei Inai Eriko Shimada Tokuko Shinohara Source Type: research
More News: Atenolol | Bisoprolol | Cardiology | Coreg | Heart | Heart Disease | Inderal | Nadolol | Perinatology & Neonatology | Pregnancy | Toprol | Women